Procedure Start Date for National Variations

Here you can see a table indicating when we initiated the review of each national variation in the order books. The variation will appear in the table until the case has been approved/refused. This table replaces the procedure start date letter that we used to send to applicants in connection with the initiation of a variation.

The "1st assessment" phase is the period from the procedure start date to the submission of a possible intended refusal. The "2nd assessment" phase is the period from the submission of a possible intended refusal until a decision has been made (including clock-stop days). The "Closing" phase is the period during which the decision is implemented. If an intended refusal is not given, the case passes directly from the "1st assessment" phase to the "Closing" phase".

The case number and CESP submission ID represent anonymised variation applications known only to the applicant and the Danish Medicines Agency. The case flow is within the deadlines that apply to variations after the procedure start date. The Danish Medicines Agency informs the applicant by letter when a variation has been closed. The list is updated daily.

If you have any questions or are unsure which case number to use for the table, please send an email to: Send an email

Sagsnummer CESP indsendelses ID Procedurestart Fase
2022090998 1696939 07/06/2023 2. Evaluering
2022123249 1821391 08/09/2023 2. Evaluering
2023050267 1896074 11/10/2023 2. Evaluering
2023091461 1968802 10/11/2023 2. Evaluering
2024011099 2034514 22/02/2024 2. Evaluering
2024022493 2057557 23/02/2024 2. Evaluering
2025020109 2249946 18/08/2025 1. Evaluering
2025042933 2288119 10/06/2025 1. Evaluering
2025100590 2367563 05/01/2026 1. Evaluering
2025102790 2374628 20/03/2026 1. Evaluering
2026010128 2415408 09/04/2026 1. Evaluering
2026011906 2420057 10/04/2026 2. Evaluering
2026012176 2422592 07/07/2026 2. Evaluering
2026012659 2422976 07/07/2026 2. Evaluering
2026021131 2435358 16/06/2026 1. Evaluering
2026021508 2436587 14/07/2026 1. Evaluering
2026022262 2438122 29/09/2026 1. Evaluering
2026022854 2439797 28/07/2026 1. Evaluering
2026022856 2439799 28/07/2026 1. Evaluering
2026031548 2449740 05/08/2026 1. Evaluering
2026031596 2449488 12/05/2026 2. Evaluering
2026033857 2456158 26/05/2026 2. Evaluering
2026035100 2457064 23/04/2026 1. Evaluering
2026035590 2459981 27/07/2026 1. Evaluering
2026035590 2459981 27/07/2026 2. Evaluering
2026035590 2459981 27/07/2026 Afslutning
2026042333 2466929 29/06/2026 Afslutning
2026043879 2470886 15/06/2026 2. Evaluering
2026050237 2474413 01/06/2026 Afslutning
2026050771 2475572 22/08/2026 1. Evaluering
2026050848 2475357 10/06/2026 1. Evaluering
2026060053 2486461 17/08/2026 1. Evaluering
2026061026 2488177 21/08/2026 1. Evaluering
2026061027 2489209 27/08/2026 1. Evaluering
2026061029 2489282 24/08/2026 2. Evaluering
2026061518 2490274 09/09/2026 1. Evaluering
2026062303 2492698 10/07/2026 1. Evaluering
2026064602 2499412 28/08/2026 1. Evaluering
2026064863 2500108 28/08/2026 1. Evaluering
2026070656 2503169 17/09/2026 1. Evaluering
2026070658 2503260 18/09/2026 2. Evaluering
2026071089 2503405 04/09/2026 2. Evaluering
2026071392 2503798 12/08/2026 1. Evaluering
2026072417 2507808 30/07/2026 1. Evaluering
2026072855 2509073 08/09/2026 2. Evaluering
2026072887 2509604 23/09/2026 1. Evaluering
2026073036 2510114 14/09/2026 Afslutning
2026073355 2511425 29/09/2026 1. Evaluering
2026073487 2512116 28/09/2026 1. Evaluering
2026074013 2513842 17/09/2026 1. Evaluering
2026074191 2513495 11/09/2026 1. Evaluering
2026080340 2515982 07/08/2026 1. Evaluering
2026080421 2514936 23/09/2026 1. Evaluering
2026081663 2518371 18/09/2026 Afslutning
2026082500 2511559 02/09/2026 1. Evaluering
2026082597 2521037 30/09/2026 1. Evaluering
2026083370 2523296 23/09/2026 2. Evaluering
2026083604 2505992 02/09/2026 1. Evaluering
2026090267 2525865 10/09/2026 2. Evaluering
2026090526 2527053 23/09/2026 Afslutning
2026090875 2527537 24/09/2026 1. Evaluering
2026092335 2532295 09/10/2026 1. Evaluering
2026094639 2532317 13/10/2026 1. Evaluering